找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Radiotherapy in Skin Cancer; A Practical Guide on Kurian Jones Joseph,Michael J. Veness,Agata Rembie Book 2023 The Editor(s) (if applicable

[復(fù)制鏈接]
樓主: Concave
21#
發(fā)表于 2025-3-25 06:28:26 | 只看該作者
22#
發(fā)表于 2025-3-25 09:43:00 | 只看該作者
Lipry and primary radical radiotherapy are equal treatment modalities for early-stage carcinomas; adjuvant radiotherapy improves outcomes for those with lip carcinomas with high-risk features..The evidence base lacks prospective data on patient-reported outcome measures and quality-of-life metrics; dat
23#
發(fā)表于 2025-3-25 15:08:48 | 只看該作者
Ear ear is a high-risk region for locoregional recurrence. Treatment planning can be challenging given the irregular surface contours of the ear. Treatment may be delivered with kilovoltage, electrons, photons, and brachytherapy depending on the site of disease presentation.
24#
發(fā)表于 2025-3-25 18:41:12 | 只看該作者
25#
發(fā)表于 2025-3-25 20:40:00 | 只看該作者
Primary Melanoma and Lentigo Maligna after complete excision of a primary melanoma to reduce local recurrence based on certain pathological indications. RT is rarely used as the primary treatment for certain patients with unresectable primary melanoma after multidisciplinary team discussion. For lentigo maligna, RT is an acceptable no
26#
發(fā)表于 2025-3-26 00:08:26 | 只看該作者
Merkel Cell Carcinomaere on the body, and most (50–60%) patients present with a primary lesion with the incidence of subclinical nodal spread high (30–50%). There is an extensive body of evidence supporting the addition of adjuvant radiotherapy in improving locoregional control and survival. Patients are often not suita
27#
發(fā)表于 2025-3-26 07:49:57 | 只看該作者
28#
發(fā)表于 2025-3-26 11:58:38 | 只看該作者
Regional Radiotherapy in Head and Neck Non-melanoma Skin Cancernd neck region. Optimal management of NMSC with metastatic regional disease involves surgery and adjuvant radiotherapy (RT). Elective nodal RT may occasionally be considered in select cases with a high-risk primary character. The addition of chemotherapy to RT in locoregionally advanced cutaneous sq
29#
發(fā)表于 2025-3-26 13:22:43 | 只看該作者
30#
發(fā)表于 2025-3-26 19:30:50 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-14 22:12
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
西吉县| 江城| 米林县| 大余县| 岫岩| 乐至县| 石渠县| 德化县| 闽清县| 永仁县| 漳浦县| 白水县| 盐城市| 会昌县| 酉阳| 邯郸县| 铜梁县| 千阳县| 大丰市| 炎陵县| 定结县| 三都| 定兴县| 怀集县| 丹巴县| 泸溪县| 云阳县| 神农架林区| 广州市| 黔江区| 德昌县| 宁夏| 慈利县| 延长县| 黎平县| 金昌市| 宣恩县| 靖西县| 揭东县| 宜兴市| 同江市|